UBS Group’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.1M Sell
532,778
-100,196
-16% -$7.31M 0.01% 1949
2026
Q1
$41.3M Sell
632,974
-114,898
-15% -$8.53M 0.01% 1839
2025
Q4
$59.3M Buy
747,872
+154,436
+26% +$11.8M 0.01% 1450
2025
Q3
$43.3M Sell
593,436
-21,440
-3% -$1.57M 0.01% 1783
2025
Q2
$46.6M Buy
614,876
+36,447
+6% +$2.58M 0.01% 1587
2025
Q1
$44M Buy
578,429
+87,024
+18% +$6.48M 0.01% 1599
2024
Q4
$32.5M Buy
491,405
+70,921
+17% +$4.96M 0.01% 1849
2024
Q3
$29.3M Buy
420,484
+25,576
+6% +$1.54M 0.01% 1541
2024
Q2
$20.9M Buy
+394,908
New +$24M 0.01% 1640

Other funds holding SOLV

UBS Group's SOLV Position: Q2 2026 in Review

UBS Group reduced its Solventum (SOLV) stake by 16% in Q2 2026, selling an estimated $7.31M and leaving 532,778 shares worth $41.1M. The position accounts for 0.01% of the portfolio, ranked #1949.

UBS Group first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $59.3M in Q4 2025. 873 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • UBS Group held 532,778 shares of Solventum worth $41.1M as of Q2 2026.
  • UBS Group sold 100,196 Solventum shares in Q2 2026, an estimated $7.31M.
  • Solventum made up 0.01% of UBS Group's portfolio in Q2 2026, its #1949 holding.
  • UBS Group first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • UBS Group's Solventum position peaked at $59.3M in Q4 2025.
  • 873 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.